Confirmation of the Neurophysiologically Predicted Therapeutic Effects of Trazodone on Its Target Symptoms Depression, Anxiety and Insomnia by Postmarketing Clinical Studies with a Controlled-Release Formulation in Depressed Outpatients

Publisher： Karger

E-ISSN： 1423-0224|48|4|194-208

ISSN： 0302-282x

Source： Neuropsychobiology, Vol.48, Iss.4, 2003-12, pp. : 194-208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insomnia in Somatoform Pain Disorder: Sleep Laboratory Studies on Differences to Controls and Acute Effects of Trazodone, Evaluated by the Somnolyzer 24 × 7 and the Siesta Database

By  

Neuropsychobiology, Vol. 51, Iss. 3, 2005-05 ,pp. : 148-163

Karger

Access to resources Recommend Favorite

Open-Label Evaluation of Venlafaxine Sustained Release in Outpatients with Generalized Anxiety Disorder with Comorbid Major Depression or Dysthymia: Effectiveness, Tolerability and Predictors of Response

By  

Neuropsychobiology, Vol. 46, Iss. 3, 2002-11 ,pp. : 145-149

Karger

Access to resources Recommend Favorite

Insomnia Related to Dysthymia: Polysomnographic and Psychometric Comparison with Normal Controls and Acute Therapeutic Trials with Trazodone

By  

Neuropsychobiology, Vol. 44, Iss. 3, 2001-09 ,pp. : 139-149

Karger

Access to resources Recommend Favorite

Placebo-Controlled Sleep Laboratory Studies on the Acute Effects of Zolpidem on Objective and Subjective Sleep and Awakening Quality in Nonorganic Insomnia Related to Neurotic and Stress-Related Disorder

By  

Neuropsychobiology, Vol. 41, Iss. 3, 2000-03 ,pp. : 139-148

Karger

Access to resources Recommend Favorite

Motor Activity and Depression Severity in Adolescent Outpatients

By  

Neuropsychobiology, Vol. 61, Iss. 1, 2009-11 ,pp. : 33-40

Karger

Access to resources Recommend Favorite